166 related articles for article (PubMed ID: 8463769)
1. Low blood pressure and blood glucose levels in Alzheimer's disease. Evidence for a hypometabolic disorder?
Landin K; Blennow K; Wallin A; Gottfries CG
J Intern Med; 1993 Apr; 233(4):357-63. PubMed ID: 8463769
[TBL] [Abstract][Full Text] [Related]
2. Differences in peripheral oxidative stress markers in Alzheimer's disease, vascular dementia and mixed dementia patients.
Hatanaka H; Hanyu H; Fukasawa R; Hirao K; Shimizu S; Kanetaka H; Iwamoto T
Geriatr Gerontol Int; 2015 Dec; 15 Suppl 1():53-8. PubMed ID: 26671158
[TBL] [Abstract][Full Text] [Related]
3. Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia.
Paragh G; Balla P; Katona E; Seres I; Egerházi A; Degrell I
Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):63-7. PubMed ID: 12111338
[TBL] [Abstract][Full Text] [Related]
4. Atherosclerosis, Hypertension, and Diabetes in Alzheimer's Disease, Vascular Dementia, and Mixed Dementia: Prevalence and Presentation.
Javanshiri K; Waldö ML; Friberg N; Sjövall F; Wickerström K; Haglund M; Englund E
J Alzheimers Dis; 2018; 65(4):1247-1258. PubMed ID: 30149459
[TBL] [Abstract][Full Text] [Related]
5. Regulation of the hypothalamic-pituitary-adrenal axis in dementia disorders.
Gottfries CG; Balldin J; Blennow K; Bråne G; Karlsson I; Regland B; Wallin A
Ann N Y Acad Sci; 1994 Nov; 746():336-43; discussion 343-4. PubMed ID: 7825888
[TBL] [Abstract][Full Text] [Related]
6. Weight, blood pressure, osmolarity, and glucose levels across various stages of Alzheimer's disease and vascular dementia.
Hogan DB; Ebly EM; Rockwood K
Dement Geriatr Cogn Disord; 1997; 8(3):147-51. PubMed ID: 9137891
[TBL] [Abstract][Full Text] [Related]
7. Lipids' peroxidation markers in Alzheimer's disease and vascular dementia.
Gustaw-Rothenberg K; Kowalczuk K; Stryjecka-Zimmer M
Geriatr Gerontol Int; 2010 Apr; 10(2):161-6. PubMed ID: 20446930
[TBL] [Abstract][Full Text] [Related]
8. Uric Acid and High-Density Lipoprotein Cholesterol Are Differently Associated with Alzheimer's Disease and Vascular Dementia.
Liu H; Reynolds GP; Wei X
J Alzheimers Dis; 2020; 73(3):1125-1131. PubMed ID: 31884488
[TBL] [Abstract][Full Text] [Related]
9. Can PET data differentiate Alzheimer's disease from vascular dementia?
Nagata K; Maruya H; Yuya H; Terashi H; Mito Y; Kato H; Sato M; Satoh Y; Watahiki Y; Hirata Y; Yokoyama E; Hatazawa J
Ann N Y Acad Sci; 2000 Apr; 903():252-61. PubMed ID: 10818514
[TBL] [Abstract][Full Text] [Related]
10. A population study on blood-brain barrier function in 85-year-olds: relation to Alzheimer's disease and vascular dementia.
Skoog I; Wallin A; Fredman P; Hesse C; Aevarsson O; Karlsson I; Gottfries CG; Blennow K
Neurology; 1998 Apr; 50(4):966-71. PubMed ID: 9566380
[TBL] [Abstract][Full Text] [Related]
11. Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia.
Watanabe T; Miyazaki A; Katagiri T; Yamamoto H; Idei T; Iguchi T
J Am Geriatr Soc; 2005 Oct; 53(10):1748-53. PubMed ID: 16181175
[TBL] [Abstract][Full Text] [Related]
12. Small dense low-density lipoprotein and carotid atherosclerosis in relation to vascular dementia.
Watanabe T; Koba S; Kawamura M; Itokawa M; Idei T; Nakagawa Y; Iguchi T; Katagiri T
Metabolism; 2004 Apr; 53(4):476-82. PubMed ID: 15045695
[TBL] [Abstract][Full Text] [Related]
13. Role of inflammatory and hemostatic biomarkers in Alzheimer's and vascular dementia - A pilot study from a tertiary center in Northern India.
Vishnu VY; Modi M; Garg VK; Mohanty M; Goyal MK; Lal V; Mittal BR; Prabhakar S
Asian J Psychiatr; 2017 Oct; 29():59-62. PubMed ID: 29061429
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic dysfunction in dementia.
Gottfries CG; Balldin J; Blennow K; Bråne G; Karlsson I; Regland B; Wallin A
J Neural Transm Suppl; 1994; 43():203-9. PubMed ID: 7884401
[TBL] [Abstract][Full Text] [Related]
15. Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia.
Yasutake C; Kuroda K; Yanagawa T; Okamura T; Yoneda H
Eur Arch Psychiatry Clin Neurosci; 2006 Oct; 256(7):402-6. PubMed ID: 16783499
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.
Varma AR; Adams W; Lloyd JJ; Carson KJ; Snowden JS; Testa HJ; Jackson A; Neary D
Acta Neurol Scand; 2002 Apr; 105(4):261-9. PubMed ID: 11939938
[TBL] [Abstract][Full Text] [Related]
17. Vascular characteristics of patients with dementia.
Morović S; Jurasić MJ; Martinić Popović I; Serić V; Lisak M; Demarin V
J Neurol Sci; 2009 Aug; 283(1-2):41-3. PubMed ID: 19375085
[TBL] [Abstract][Full Text] [Related]
18. Vasoreactivity induced by acetazolamide in patients with vascular dementia versus Alzheimer's disease.
Likitjaroen Y; Suwanwela NC; Phanthumchinda K
J Neurol Sci; 2009 Aug; 283(1-2):32-5. PubMed ID: 19375084
[TBL] [Abstract][Full Text] [Related]
19. Neuropsychiatric symptoms in dementia-frequency, relationship to dementia severity and comparison in Alzheimer's disease, vascular dementia and frontotemporal dementia.
Srikanth S; Nagaraja AV; Ratnavalli E
J Neurol Sci; 2005 Sep; 236(1-2):43-8. PubMed ID: 15964021
[TBL] [Abstract][Full Text] [Related]
20. The role of human kallikrein 6, clusterin and adiponectin as potential blood biomarkers of dementia.
Dukic L; Simundic AM; Martinic-Popovic I; Kackov S; Diamandis A; Begcevic I; Diamandis EP
Clin Biochem; 2016 Feb; 49(3):213-8. PubMed ID: 26515085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
